This ROS production alters some cell function, such as cell migration, apoptosis, inflammation, and the epithelial-mesenchymal transition, which is required for cancer initiation, by disrupting the balance of cellular ROS generated by the AhR-Nrf2 gene battery. This evidence concerns the gene AHR and cancer.